TrademarkDir
BIOZOL TRANSDERMAL SERUM
LIVE

Serial Number

87316486

Owner

Nexzol Pharma, Inc.

Attorney

Sean B. MacKenzie

First Use Date

Aug 18, 2020

Filing Date

Jan 27, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BIOZOL TRANSDERMAL SERUM Trademark

Serial Number: 87316486 • Registration: 6175489

BIOZOL TRANSDERMAL SERUM is a trademark filed by Nexzol Pharma, Inc. on January 27, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Nexzol Pharma, Inc. (9 trademarks)

1001 Avenida Pico, Suite C-501
San Clemente, CA 92673

Entity Type: 03

Nuremedy Pharma LLC

Suite 100
Las Vegas, NV 89144

Entity Type: 16

Trademark Details

Filing Date

January 27, 2017

Registration Date

October 13, 2020

First Use Anywhere

August 18, 2020

First Use in Commerce

August 18, 2020

Published for Opposition

July 4, 2017

Goods & Services

Pharmaceutical formulation for transcutaneous drug delivery for the treatment of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak, and poison sumac

Filing History

TEAS SECTION 8 RECEIVED
Jul 17, 2026 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 13, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 13, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 11, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 10, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 24, 2020 SUPC
USE AMENDMENT FILED
Aug 18, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 18, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2020 EXRA
SOU EXTENSION 5 GRANTED
Jan 7, 2020 EX5G
SOU EXTENSION 5 FILED
Dec 12, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 12, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 26, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jul 24, 2019 EX4G
SOU EXTENSION 4 FILED
Jul 24, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 24, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2019 EXRA
SOU EXTENSION 3 GRANTED
Feb 26, 2019 EX3G
SOU EXTENSION 3 FILED
Feb 26, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 26, 2019 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2019 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 31, 2018 EXRA
SOU EXTENSION 2 GRANTED
Aug 30, 2018 EX2G
SOU EXTENSION 2 FILED
Aug 23, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 23, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2018 EXRA
SOU EXTENSION 1 GRANTED
May 4, 2018 EX1G
RESPONSE TO ITU OFFICE ACTION ENTERED
Mar 5, 2018 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2018 TROA
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Feb 9, 2018 INCE
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 9, 2018 AITU
SOU EXTENSION 1 FILED
Feb 5, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 5, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 29, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 4, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jul 4, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 14, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 27, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 27, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2017 CNEA
ASSIGNED TO EXAMINER
Apr 24, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 31, 2017 NWOS
NEW APPLICATION ENTERED
Jan 31, 2017 NWAP

Related Trademarks

More from this Owner

NEXREMEDY

NEXREMEDY

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL